Bangladesh buying Chinese COVID-19 vaccines at double rate than India's Oxford-AstraZeneca
Dhaka: Bangladesh has approved the proposal to purchase 15 million COVID-19 vaccine doses from China even by paying more than the rate the country needed to procure AstraZeneca vaccine from India, media reports said.
Each dose of China’s Sinopharm vaccine will be priced at $10, Shahida Akhter, additional secretary of the Cabinet Division, was quoted as saying by bdnews24 at a media briefing on Thursday.
Shipments will arrive in Bangladesh in three phases, starting in June, with five million doses in each consignment, reports the news portal.
Bangladesh had run its inoculation drive against COVID-19 with the Oxford-AstraZeneca vaccine from the Serum Institute of India, which it bought for $5 per dose. The Chinese vaccine will cost Bangladesh double the Oxford-AstraZeneca shot, reports bdnews24.
Bangladesh has been hit by COVID-19 virus since the pandemic started in the country last year.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.